Therapeutic management and clinical outcome of autoimmune pancreatitis
Authors:
- Raffaele PezzilliRPRaffaele Pezzilli
- Giulio CarianiGCGiulio Cariani
- Donatella SantiniDSDonatella Santini
- Lucia CalculliLCLucia Calculli
- Riccardo CasadeiRCRiccardo Casadei
- Antonio Maria Morselli-LabateAMAntonio Maria Morselli-Labate
- Roberto CorinaldesiRCRoberto Corinaldesi
- 30 May 2011
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 46 (9) , 1029-1038
Abstract
Autoimmune pancreatitis, in comparison to other benign chronic pancreatic diseases, is characterized by the possibility of curing the illness with immunosuppressant drugs. The open question is whether to differentiate autoimmune pancreatitis as a primary or secondary disease based on the presence or absence of other autoimmune diseases or whether to consider autoimmune pancreatitis a clinical and pathological systemic entity, called IgG4-related sclerosing disease, since this aspect is also very important from a therapeutic point of view. In this paper, we reviewed the conventional therapeutic approach used to treat autoimmune pancreatitis patients and the clinical outcome related to each treatment modality. We also reviewed some aspects which are important for the correct management of autoimmune pancreatitis, such as the surgical approach, the outcome of surgically treated autoimmune pancreatitis patients, whether medical treatment is always necessary, and, finally, when medical treatment should be initiated. Steroids are useful in alleviating the symptoms of the acute presentation of autoimmune pancreatitis, but some questions remain open such as the dosage of steroids in the acute phase and the duration of steroid therapy; finally, it should be assessed if other immunosuppressive non-steroidal drugs may become the first-line therapy in patients with AIP without jaundice and without atrophic pancreas.Keywords
This publication has 51 references indexed in Scilit:
- Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta‐analysisJournal of Gastroenterology and Hepatology, 2009
- Autoimmune Pancreatitis Associated with High Levels of Chromogranin A, Serotonin and 5-Hydroxyindoleacetic AcidCase Reports in Gastroenterology, 2008
- Optimising corticosteroid treatment for autoimmune pancreatitisGut, 2007
- Autoimmune pancreatitis diagnosed after pancreatoduodenectomy and successfully treated with low-dose steroidJournal of Hepato-Biliary-Pancreatic Surgery, 2007
- Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatmentGut, 2007
- Autoimmune pancreatitis: a message from JapanJournal of Gastroenterology, 2007
- Autoimmune pancreatitis associated with anisakis infectionDigestive and Liver Disease, 2007
- Autoimmune pancreatitis: an underdiagnosed condition in CaucasiansJournal of Hepato-Biliary-Pancreatic Surgery, 2005
- Response to steroid therapy of sclerosing cholangitis after duodenopancreatectomy due to autoimmune pancreatitis: Figure 1Gut, 2005
- Case 27-2003New England Journal of Medicine, 2003